Evaluating the Health Economic Impacts of Baloxavir Marboxil and Oseltamivir for the Treatment of Influenza in Adult Outpatients in Hong Kong: A Cost‐Effectiveness Analysis

Published in Influenza and Other Respiratory Viruses, 2026

Recommended citation: Chen, Ruohan, Zengyang Shao, Kaiming Bi, Benjamin John Cowling, and Zhanwei Du. "Evaluating the Health Economic Impacts of Baloxavir Marboxil and Oseltamivir for the Treatment of Influenza in Adult Outpatients in Hong Kong: A Cost‐Effectiveness Analysis." Influenza and Other Respiratory Viruses 20, no. 3 (2026): e70243.

[[PDF]](https://pmc.ncbi.nlm.nih.gov/articles/PMC12962020/pdf/IRV-20-e70243.pdf)